These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

288 related items for PubMed ID: 24898423

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Uric acid and risk of periprocedural myocardial infarction in patients undergoing percutaneous coronary intervention.
    Verdoia M, Schaffer A, Barbieri L, Di Giovine G, Marino P, De Luca G, Novara Atherosclerosis Study Group (NAS).
    Diabetes Metab Res Rev; 2014 May; 30(4):297-304. PubMed ID: 24829966
    [Abstract] [Full Text] [Related]

  • 4. Glycosylated hemoglobin and the risk of periprocedural myocardial infarction in non-diabetic patients.
    Verdoia M, Schaffer A, Barbieri L, Di Giovine G, Marino P, Suryapranata H, De Luca G, Novara Atherosclerosis Study Group (NAS).
    J Diabetes Complications; 2015 May; 29(4):517-22. PubMed ID: 25736187
    [Abstract] [Full Text] [Related]

  • 5. Platelet-larger cell ratio and the risk of periprocedural myocardial infarction after percutaneous coronary revascularization.
    Verdoia M, Barbieri L, Schaffer A, Cassetti E, Marino P, Bellomo G, Sinigaglia F, De Luca G, Novara Atherosclerosis Study Group (NAS).
    Heart Vessels; 2015 Jan; 30(1):20-7. PubMed ID: 24297745
    [Abstract] [Full Text] [Related]

  • 6. Plaque Characterization to Inform the Prediction and Prevention of Periprocedural Myocardial Infarction During Percutaneous Coronary Intervention: The CANARY Trial (Coronary Assessment by Near-infrared of Atherosclerotic Rupture-prone Yellow).
    Stone GW, Maehara A, Muller JE, Rizik DG, Shunk KA, Ben-Yehuda O, Genereux P, Dressler O, Parvataneni R, Madden S, Shah P, Brilakis ES, Kini AS, CANARY Investigators.
    JACC Cardiovasc Interv; 2015 Jun; 8(7):927-36. PubMed ID: 26003018
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Platelet distribution width and the risk of periprocedural myocardial infarction in patients undergoing percutaneous coronary intervention.
    Verdoia M, Barbieri L, Schaffer A, Cassetti E, Di Giovine G, Bellomo G, Marino P, Sinigaglia F, De Luca G.
    J Thromb Thrombolysis; 2014 Apr; 37(3):345-52. PubMed ID: 23793523
    [Abstract] [Full Text] [Related]

  • 10. Platelet HPA-1 a/HPA-1 b polymorphism and the risk of periprocedural myocardial infarction in patients undergoing elective PCI.
    Verdoia M, Secco GG, Barbieri L, Cassetti E, Schaffer A, Sinigaglia F, Marino P, Suryapranata H, De Luca G, Novara Atherosreclerosis Study Group (NAS).
    Platelets; 2014 Apr; 25(5):367-72. PubMed ID: 24283589
    [Abstract] [Full Text] [Related]

  • 11. Impact of pre-procedural dual antiplatelet therapy on periprocedural myocardial infarction in patients undergoing percutaneous coronary interventions with adjunctive tirofiban.
    Verdoia M, Pergolini P, Barbieri L, Rolla R, Nardin M, Negro F, Suryapranata H, De Luca G, Novara Atherosclerosis Study Group (NAS).
    Thromb Res; 2018 Apr; 164():17-23. PubMed ID: 29475177
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Impact of the Polymorphism rs5751876 of the Purinergic Receptor ADORA2A on Periprocedural Myocardial Infarction in Patients Undergoing Percutaneous Coronary Intervention.
    Negro F, Verdoia M, Nardin M, Suryapranata H, Kedhi E, Dudek D, De Luca G, Novara Atherosclerosis Study Group (NAS).
    J Atheroscler Thromb; 2021 Feb 01; 28(2):137-145. PubMed ID: 33342966
    [Abstract] [Full Text] [Related]

  • 15. Point-of-care assessment of platelet reactivity after clopidogrel to predict myonecrosis in patients undergoing percutaneous coronary intervention.
    Mangiacapra F, Barbato E, Patti G, Gatto L, Vizzi V, Ricottini E, D'Ambrosio A, Wijns W, Di Sciascio G.
    JACC Cardiovasc Interv; 2010 Mar 01; 3(3):318-23. PubMed ID: 20298992
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. The prognosis of periprocedural myocardial infarction after percutaneous coronary interventions.
    Zimarino M, Affinito V.
    Cardiovasc Revasc Med; 2013 Mar 01; 14(1):32-6. PubMed ID: 23164601
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. MTHFR polymorphism and risk of periprocedural myocardial infarction after coronary stenting.
    Verdoia M, Schaffer A, Cassetti E, Barbieri L, Di Giovine G, Marino P, De Luca G, Novara Atherosclerosis Study Group (NAS).
    Nutr Metab Cardiovasc Dis; 2014 May 01; 24(5):532-7. PubMed ID: 24418373
    [Abstract] [Full Text] [Related]

  • 20. Differential mortality risk of postprocedural creatine kinase-MB elevation following successful versus unsuccessful stent procedures.
    Jeremias A, Baim DS, Ho KK, Chauhan M, Carrozza JP, Cohen DJ, Popma JJ, Kuntz RE, Cutlip DE.
    J Am Coll Cardiol; 2004 Sep 15; 44(6):1210-4. PubMed ID: 15364321
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 15.